Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 184 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: No Conditions Clear all

Conditions: Individual, Category, and No-label Conditions
Interventions: Effects of shared book reading: Labels; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 5 Months to 65 Years
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Postoperative Pain, Inguinal Hernia
Interventions: Opioids, No opioids; Drug · Other
Lead sponsor: Clayton Petro; Other
Eligibility: 18 Years and older
Enrollment: 904 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Fountain Valley, California • Royal Oak, Michigan • Cleveland, Ohio + 3 more

Conditions: Analgesia, IUD Insertion
Interventions: Lidocaine, No analgesia, Intrauterine device (IUD); Drug · Other · Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Solid Tumors
Interventions: I-131-CLR1404; Drug
Lead sponsor: Cellectar, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 4
States / cities: Duarte, California • Washington D.C., District of Columbia • Baltimore, Maryland + 1 more

Conditions: No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG
Interventions: Virtual human social interaction, Cold pressor test; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Downey, California • Los Angeles, California

Conditions: Intellectual Disability
Interventions: Physical Literacy & Food Literacy Intervention.; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 12 Years to 16 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Hearing Loss, Bilateral (Causes Other Than Tumors)
Interventions: Nucleus ABI541 Auditory Brainstem Implant; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Months to 21 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Retinitis Pigmentosa, Retinitis, Retinal Diseases, Eye Diseases, Eye Diseases, Hereditary, Retinal Dystrophies, Retinal Degeneration
Interventions: Gene Therapy Product-MCO-010, Sham Injection; Biological · Procedure
Lead sponsor: Nanoscope Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Beverly Hills, California • Pensacola, Florida • Fargo, North Dakota + 2 more

Conditions: Intermittent Claudication
Interventions: Placebo, Sapropterin Dihydrochloride; Other · Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 17
States / cities: Scottsdale, Arizona • Sacramento, California • San Diego, California + 14 more

Conditions: Out-of-Hospital Cardiac Arrest, Hypothermia, Cardiac Arrest
Interventions: Early Angiography; Procedure
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 4
States / cities: Tucson, Arizona • Portland, Maine • Rochester, Minnesota

Conditions: Barrett Esophagus, Intestinal Metaplasia, Esophageal Dysplasia
Interventions: CryoBalloon Focal Ablation System; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 11
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Baltimore, Maryland + 8 more

Conditions: Chronic Sinusitis
Interventions: Seprapack Sinus Dressing; Device
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 3
States / cities: Charleston, North Carolina • Cincinnati, Ohio • Memphis, Tennessee

Conditions: Microvascular Angina, Angina Pectoris
Interventions: Quality of Life assessment, Stress imaging; Other · Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: No Conditions
Interventions: Health Education, Health Education Training; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Myocardial Infarction
Interventions: Tenecteplase, Sterile Saline; Drug
Lead sponsor: C. Michael Gibson, MS, MD; Other
Eligibility: 18 Years to 74 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 8
States / cities: Gainesville, Florida • Atlanta, Georgia • Decatur, Georgia + 4 more

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Voice of Sleep "MamaBee" training modules (Fairy Tales); Device
Lead sponsor: Pisareva Citadel Group LLC; Other
Eligibility: 8 Years to 18 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: NewYork, New York

Conditions: Fatigue
Interventions: Sildenafil, tadalafil, Placebo; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 50 Years to 60 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Chronic Limb Threatening Ischemia
Interventions: Transverse Tibial Bone Transport, TrueLok Elevate; Procedure · Device
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 95 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Postoperative Pain, Opioid Use, Prolapse; Female, Incontinence
Interventions: Standard opioid prescribing, Restrictive opioid prescribing; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: No Condition
Interventions: chloroprocaine HCL 3%, Subconjunctival Lidocaine; Drug
Lead sponsor: Retina Research Institute, LLC; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Glen Carbon, Illinois • Chesterfield, Missouri • City of Saint Peters, Missouri + 1 more

Conditions: Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura, Sarcoma, Melanoma
Interventions: H1299 cell lysates, Cyclophosphamide, Celecoxib, Iscomatrix adjuvant; Biological · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: No Disease or Condition is Being Studied
Interventions: Esports Ergonomic Protocol; Other
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: No Condition, Assessment of Healthy Volunteers
Interventions: Acute exercise-moderate intensity, Acute effects-heavy intensity; Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 20 Years to 40 Years
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Anemia, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose, placebo; Biological · Dietary Supplement · Drug + 1 more
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 502 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Search by objective public record fields.

Infant and Parent Shared Book Reading

No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair

Paracervical Block Versus No Paracervical Block During IUD Insertion

Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States

New Skills - No Scores Research Study

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]

A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease

Early Coronary Angiography Versus Delayed Coronary Angiography

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery

Changes in Ischemia and Angina Over 1 Year Among ISCHEMIA Trial Screen Failures With no Obstructive CAD on Coronary CT Angiography

Health Management Training to Enhance Influenza Vaccine Immunogenicity

A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks

Methodology of Super-Early Training of Developer Engineers and Leading Analysts With a Diagnosis of ADHD/ASD for Ensuring the Engineering Sovereignty of the State: Time Horizon: 2026-2038-2050

The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

STandard Versus No Opioid Prescription After Prolapse and Anti-INcontinence Surgery Trial

Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus Subconjunctival Lidocaine (2%): A Randomized, Controlled Trial

Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Ergonomic Protocol for Competitive E-Sport Athletes

Immunometabolism of Exercise

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer